Tunn, Per-Ulf

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., et al. (2015) · Journal of Clinical Oncology

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 422

Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

Kovac, M., Blattmann, C., Ribi, S., Smida, J., Mueller, N. S., Engert, F., Castro-Giner, F., Weischenfeldt, J., Kovacova, M., Krieg, A., et al. (2015) · Nature Communications

Sarcoma Diagnosis and TreatmentCancer Genomics and Diagnostics

Cited by 353

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

Ferrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Sundby Hall, K., Donati, D., Kevric, M., Brosjö, O., Comandone, A., et al. (2018) · Tumori Journal

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 123

De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway

Fritsche‐Guenther, R., Noske, A., Ungethüm, U., Kuban, R., Schlag, P. M., Tunn, P., Karle, J., Krenn, V., Dietel, M., & Sers, C. (2010) · Histopathology

Sarcoma Diagnosis and TreatmentAxon Guidance and Neuronal Signaling

Cited by 69